TAIHO PHARMA

Exploring hidden
possibilities for
people awaiting
new medicines

About Taiho

Becoming a truly global specialty pharma that meets the expectations of patients worldwide.

Our Business

Taiho Pharmaceutical creates innovative, highly valuable new drugs to support patients and the advancement of medicine, seeking to contribute to smiles and health for people all around the world.

News Releases

September 04, 2020

Taiho Pharmaceutical Adds New Orange and Lychee Flavors to the Pitas Throat Troche Lineup
September 01, 2020

Taiho Pharmaceutical Adopts Carbon-Neutral Electricity
Annual CO₂ Emissions to Decline by Approximately 13% in the Tsukuba Area（PDF：98.9 KB）
July 28, 2020

Taiho Pharmaceutical Launches Anticancer Agent LONSURF^® (brand name in Japan) in China for Treatment of Colorectal Cancer
July 08, 2020

Taiho announces simultaneous regulatory approvals by U.S. FDA and Health Canada of INQOVI^®, an oral hypomethylating agent (HMA) therapy for MDS and CMML（PDF：514.9 KB）
June 15, 2020

Taiho Pharmaceutical Submits Application for Additional Dosage and Administration of 5-HT₃ Receptor Antagonist　Aloxi_® for Pediatric Patients in Japan

Information

July 12, 2018

Announcement of Support from Otsuka Holdings and Its Group Companies in the Aftermath of Severe Storms in Japan（PDF：165.9 KB）